207 related articles for article (PubMed ID: 24350999)
1. The inherent ethical challenge of first-in-human pluripotent stem cell trials.
Habets MG; van Delden JJ; Bredenoord AL
Regen Med; 2014 Jan; 9(1):1-3. PubMed ID: 24350999
[No Abstract] [Full Text] [Related]
2. [Ethical reflections on cell reprogramming].
Aznar Lucea J; MartÃnez M
Cuad Bioet; 2012; 23(78):287-99. PubMed ID: 23130744
[TBL] [Abstract][Full Text] [Related]
3. Why regenerative stem cell medicine progresses slower than expected.
Rosemann A
J Cell Biochem; 2014 Dec; 115(12):2073-6. PubMed ID: 25079695
[No Abstract] [Full Text] [Related]
4. Regenerative nanomedicine: ethical, legal, and social issues.
Glenn LM; Boyce JS
Methods Mol Biol; 2012; 811():303-16. PubMed ID: 22042687
[TBL] [Abstract][Full Text] [Related]
5. Embryonic stem cells from blastomeres maintaining embryo viability.
Klimanskaya I
Semin Reprod Med; 2013 Jan; 31(1):49-55. PubMed ID: 23329636
[TBL] [Abstract][Full Text] [Related]
6. Stem cells create a therapeutic niche.
Dangi-Garimella S
Am J Manag Care; 2014 May; 20(8 Spec No.):E7. PubMed ID: 25617926
[No Abstract] [Full Text] [Related]
7. The significance of induced pluripotent stem cells for basic research and clinical therapy.
Meyer JR
J Med Ethics; 2008 Dec; 34(12):849-51. PubMed ID: 19043107
[TBL] [Abstract][Full Text] [Related]
8. The ethics of stem cells revisited.
de Miguel-Beriain I
Adv Drug Deliv Rev; 2015 Mar; 82-83():176-80. PubMed ID: 25446134
[TBL] [Abstract][Full Text] [Related]
9. Tempering hope with realism: induced pluripotent stem cells in regenerative medicine.
Fung RK; Kerridge IH; Skene LL; Munsie MJ
Med J Aust; 2012 Jun; 196(10):622-5. PubMed ID: 22676869
[No Abstract] [Full Text] [Related]
10. Embryo-like features of induced pluripotent stem cells defy legal and ethical boundaries.
Meskus M; de Miguel Beriain I
Croat Med J; 2013 Dec; 54(6):589-91. PubMed ID: 24382856
[No Abstract] [Full Text] [Related]
11. Hope for regenerative treatments: toward safe transplantation of human pluripotent stem-cell-based therapies.
Kimbrel EA; Lanza R
Regen Med; 2015; 10(2):99-102. PubMed ID: 25835474
[No Abstract] [Full Text] [Related]
12. [Ethical, legal and social issues in regenerative medicine].
Ida R
Nihon Rinsho; 2008 May; 66(5):991-6. PubMed ID: 18464522
[TBL] [Abstract][Full Text] [Related]
13. Situated stem cell ethics: beyond good and bad.
Liu JA
Regen Med; 2017 Sep; 12(6):587-591. PubMed ID: 28976823
[No Abstract] [Full Text] [Related]
14. [Stem cells: scientific progress and commercial tactics].
Nau JY
Rev Med Suisse; 2013 Oct; 9(400):1794-5. PubMed ID: 24187755
[No Abstract] [Full Text] [Related]
15. Advances in cell lineage reprogramming.
Zhou J; Yue W; Pei X
Sci China Life Sci; 2013 Mar; 56(3):228-33. PubMed ID: 23526388
[TBL] [Abstract][Full Text] [Related]
16. Stem cells.
Behr B; Ko SH; Wong VW; Gurtner GC; Longaker MT
Plast Reconstr Surg; 2010 Oct; 126(4):1163-1171. PubMed ID: 20555302
[TBL] [Abstract][Full Text] [Related]
17. Induced pluripotent stem cells: reprogrammed without a trace.
Nelson TJ; Terzic A
Regen Med; 2009 May; 4(3):333-5. PubMed ID: 19438303
[No Abstract] [Full Text] [Related]
18. Exploring innovation in stem cell and regenerative medicine in Japan: the power of the consortium-based approach.
Munisi HI; Xie Z; Sengoku S
Regen Med; 2014; 9(4):467-77. PubMed ID: 25159064
[TBL] [Abstract][Full Text] [Related]
19. Broadening the scope of debates around stem cell research.
Lysaght T; Campbell AV
Bioethics; 2013 Jun; 27(5):251-6. PubMed ID: 22500617
[TBL] [Abstract][Full Text] [Related]
20. Current status of stem cells and regenerative medicine research in Argentina.
Pitossi FJ; Podhajcer OL
Stem Cells Dev; 2014 Dec; 23 Suppl 1():17-9. PubMed ID: 25457955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
